OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 13

Showing 13 citing articles:

Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access

The Current Treatment Status and Outlook for Adenosquamous Carcinoma of the Lung
金原 肖
Journal of Clinical Personalized Medicine (2025) Vol. 04, Iss. 01, pp. 923-931
Open Access

A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia
Chen Luo, Yilimuguli Abudukeremu, Mingliang Rao, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access

Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access

In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma
Wenqing Jia, Xian‐Chao Cheng
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3565-3565
Open Access

METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a
Dengyun Gao, Jian Shi, Siyu Lu, et al.
Journal of Orthopaedic Surgery and Research (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
Ana Maria Waaga-Gasser, Thomas Böldicke
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13504-13504
Open Access | Times Cited: 1

Synergistic ROS Reduction Through the Co-Inhibition of BRAF and p38 MAPK Ameliorates Senescence
Myeong Uk Kuk, Duyeol Kim, Yun Haeng Lee, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1465-1465
Open Access | Times Cited: 1

Advances in Cancer Treatment and Monitoring: Insights from KRAS Inhibitors and Germline Epitope Burden Monitoring
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1815-1817
Open Access

A New Frontier in Targeted Therapies: Harnessing PROTACs and Advanced Delivery Systems
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1818-1820
Open Access

Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access

Page 1

Scroll to top